Regeneron Pharmaceuticals | REGN - Trade Debtors


Regeneron Pharmaceuticals reported $5.73B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Agenus USD 22.44M 1.14M Dec/2025
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amgen USD 9.14B 432M Mar/2026
Astellas Pharma JPY 761.76B 48.47B Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Eli Lilly USD 21.18B 1.02B Mar/2026
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Kyowa Hakko Kirin JPY 120.9B 60.31B Mar/2026
Merck USD 11.78B 345M Dec/2025
Moderna USD 71M 113M Mar/2026
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Novartis USD 9.6B 2.69B Mar/2026
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 16.17B 332M Mar/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 397M 186.13M Dec/2025
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
Teva Pharmaceutical Industries USD 3.39B 316M Mar/2026
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
United Therapeutics USD 312M 38.2M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026